2nd quarter ASP list analysis

by CHARLES FIEGL on Mar 31, 2010

Photo credit: National Institutes of Health/Department of Health and Human ServicesCMS's Average Sales Price (ASP) list is out for the second quarter of 2010 (running from April 1 through June 30). Subscribers can now download an 11-page document on the drug price changes prepared by Part B News. You'll find it in our Hot Documents folder labeled "ASP_chart_Q210." The document details all price changes from the first to second quater.

CMS contends the prices remain stable. Here's a snapshot of what our analysis has found:

  • Prices for 248 drugs will decrease from the amounts paid in the first quarter of 2010;
  • Prices for 67 drugs will not change;
  • Prices for 270 drugs will increase; and,
  • CMS issued payments for the first time for two drugs - C1 esterase inhibitor injection (J0598, $42.746) and Temozolomide injection (J9328, $4.899).

Codes J9093-J9097 for Cyclophosphamide lyophilized no longer appear on the list.

The information contained herein was current as of the publication date. © Copyright DecisionHealth, all rights reserved. Electronic or print redistribution without prior written permission of DecisionHealth is strictly prohibited by federal copyright law.